Adoptive transfer of multiple stem cell types into failing human hearts has demonstrated safety however the beneficial effects in patients with cardiovascular disorders have been modest. Despite increasing use of stem cell based therapies, there is no consensus on the optimal stem cell type. Modest repair and improvement in patients with cardiac complications warrants identification of a novel stem cell population that possesses youthful phenotype and effectively repair the heart after myocardial environment. Recently we have shown in a mouse model that cortical bone derived stem cells (CBSCs) enhance cardiac function after myocardial infarction and these beneficial effects appear largely to be mediated by paracrine mechanisms. The fundamental basis of the project is to investigate whether observed cardioprotection is mediated by secretion of exosomes from CBSCs. Our preliminary data indicates that CBSCs derived exosomes recapitulate our earlier findings with CBSCs transplantation and demonstrate effective way for cardiac repair. The hypothesis of this research is to study the molecular contents (microRNA and paracrine factors) present in exosomes derived from cortical bone stem cells. Additionally, we will test various exosome delivery approaches together with the determination of optimal exosome dose in a large clinically relevant animal model. Our proposed study will provide information on CBSCs unique protective signature molecules carried by exosomes and swine animal model for heart repair that should provide basis for developing novel therapies for treating heart failure patients.

Public Health Relevance

Cardiovascular disease is a major health problem in US leading to death of over a million people every year. Stem cell therapy has emerged as a possible solution to treat heart failure patients. However, studies performed to date report that improvement in cardiac function is insufficient due to poor retention and survival of the donated cells warranting alternate strategies. This study will investigate reparative capacity of exosomes derived from cortical bone stem cell (CBSCs) including their ability to carry cell specific miR, proteins and paracrine factors. Understanding the molecular content of exosomes derived from CBSCs will provide an insight on the mechanism for the salutary effects of CBSC therapy and providing a new way for the treatment of heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL134608-04
Application #
9980471
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Wong, Renee P
Project Start
Project End
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Sluijter, Joost Petrus Gerardus; Davidson, Sean Michael; Boulanger, Chantal M et al. (2018) Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 114:19-34
Garikipati, Venkata Naga Srikanth; Kishore, Raj (2018) Induced Pluripotent Stem Cells Derived Extracellular Vesicles: A Potential Therapy for Cardiac Repair. Circ Res 122:197-198
Cheng, Zhongjian; Shen, Xinggui; Jiang, Xiaohua et al. (2018) Hyperhomocysteinemia potentiates diabetes-impaired EDHF-induced vascular relaxation: Role of insufficient hydrogen sulfide. Redox Biol 16:215-225
Gupta, Rajesh; Mackie, Alexander R; Misener, Sol et al. (2018) Endothelial smoothened-dependent hedgehog signaling is not required for sonic hedgehog induced angiogenesis or ischemic tissue repair. Lab Invest 98:682-691
Garikipati, Venkata Naga Srikanth; Kishore, Raj (2017) Cardiac progenitor cells: old is not always gold. J Physiol 595:6221-6222
Yue, Yujia; Garikipati, Venkata Naga Srikanth; Verma, Suresh Kumar et al. (2017) Interleukin-10 Deficiency Impairs Reparative Properties of Bone Marrow-Derived Endothelial Progenitor Cell Exosomes. Tissue Eng Part A 23:1241-1250